Business Description
Diagnos Inc
NAICS : 621990
SIC : 8639
ISIN : CA2524422078
Total Employee Number:
16Description
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in a single business segment of Healthcare services. The company has a business presence in Canada, the United States of America, Mexico, Chile, and others. The company's key revenue is derived from Canada.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.37 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 2.04 | |||||
Debt-to-EBITDA | -0.35 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -30.23 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -47.7 | |||||
3-Year EBITDA Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | -9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 92.74 | |||||
9-Day RSI | 79.21 | |||||
14-Day RSI | 68.61 | |||||
3-1 Month Momentum % | -18.11 | |||||
6-1 Month Momentum % | -38.05 | |||||
12-1 Month Momentum % | 5.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.49 | |||||
Quick Ratio | 1.49 | |||||
Cash Ratio | 1.3 | |||||
Days Sales Outstanding | 66.26 | |||||
Days Payable | 1387 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.5 | |||||
Shareholder Yield % | -8.59 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.92 | |||||
Operating Margin % | -6506.15 | |||||
Net Margin % | -7006.15 | |||||
EBITDA Margin % | -6210.77 | |||||
FCF Margin % | -5708.33 | |||||
OCF Margin % | -5689.58 | |||||
ROE % | -29571.43 | |||||
ROA % | -173.08 | |||||
ROIC % | -195.44 | |||||
3-Year ROIIC % | -235.81 | |||||
ROC (Joel Greenblatt) % | -2156.31 | |||||
ROCE % | -1416.04 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 259.87 | |||||
PB Ratio | 17.7 | |||||
Price-to-Tangible-Book | 17.7 | |||||
EV-to-EBIT | -6.95 | |||||
EV-to-EBITDA | -7.17 | |||||
EV-to-Revenue | 438.44 | |||||
EV-to-Forward-Revenue | 87.34 | |||||
EV-to-FCF | -7.68 | |||||
Price-to-GF-Value | 3.54 | |||||
Earnings Yield (Greenblatt) % | -14.39 | |||||
FCF Yield % | -12.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:DGNOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diagnos Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.048 | ||
| EPS (TTM) ($) | -0.028 | ||
| Beta | 0.1277 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 45.08 | ||
| 14-Day RSI | 68.61 | ||
| 14-Day ATR ($) | 0.009269 | ||
| 20-Day SMA ($) | 0.153791 | ||
| 12-1 Month Momentum % | 5.07 | ||
| 52-Week Range ($) | 0.1282 - 0.29234 | ||
| Shares Outstanding (Mil) | 120.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diagnos Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diagnos Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2019-04-24 | 0.33 (+0.00%) |
Show
Entries
Diagnos Inc Frequently Asked Questions
What is Diagnos Inc(DGNOF)'s stock price today?
The current price of DGNOF is $0.18. The 52 week high of DGNOF is $0.29 and 52 week low is $0.13.
When is next earnings date of Diagnos Inc(DGNOF)?
The next earnings date of Diagnos Inc(DGNOF) is .
Does Diagnos Inc(DGNOF) pay dividends? If so, how much?
Diagnos Inc(DGNOF) does not pay dividend.
Guru Commentaries on OTCPK:DGNOF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Diagnos Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers